Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Local Retention and Duration of Activity of SPL7013 Following Vaginal Application of 3% SPL7013 Gel (VivaGel) in Healthy Volunteers

NCT00740584 is registered in ClinicalTrials.gov with Starpharma Pty Ltd as lead sponsor.

NCT NCT00740584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00740584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Local Retention and Duration of Activity of SPL7013 Following Vaginal Application of 3% SPL7013 Gel (VivaGel) in Healthy Volunteers
Lead sponsor
Starpharma Pty Ltd
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2008
Completion date
March 31, 2009
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, hsv-2 genital herpes